For miR-23b-3p, although significant differences were detected between triple-negative breast cancer (TNBC), luminal A, and luminal B when compared with benign breast tumors, we did not find a significant difference with the HER2-positive molecular subtype. This evidence concerns the gene ERBB2 and breast benign neoplasm.